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ABSTRACT
Predicting protein pocket’s ability to bind drug-like
molecules with high affinity, i.e. druggability, is of
major interest in the target identification phase of
drug discovery. Therefore, pocket druggability inves-
tigations represent a key step of compound clin-
ical progression projects. Currently computational
druggability prediction models are attached to one
unique pocket estimation method despite pocket es-
timation uncertainties. In this paper, we propose
‘PockDrug-Server’ to predict pocket druggability, ef-
ficient on both (i) estimated pockets guided by the
ligand proximity (extracted by proximity to a lig-
and from a holo protein structure) and (ii) estimated
pockets based solely on protein structure informa-
tion (based on amino atoms that form the surface
of potential binding cavities). PockDrug-Server pro-
vides consistent druggability results using different
pocket estimation methods. It is robust with respect
to pocket boundary and estimation uncertainties,
thus efficient using apo pockets that are challeng-
ing to estimate. It clearly distinguishes druggable
from less druggable pockets using different estima-
tion methods and outperformed recent druggability
models for apo pockets. It can be carried out from
one or a set of apo/holo proteins using different
pocket estimation methods proposed by our web
server or from any pocket previously estimated by
the user. PockDrug-Server is publicly available at:
http://pockdrug.rpbs.univ-paris-diderot.fr.
INTRODUCTION
The ability of a protein to bind drug-like molecules, which
are orally bioavailable, with a high affinity is often referred
to as druggability, as first defined by Hopkins and Groom
(1). Druggability assessment plays a key role in the first step
of drug discovery project, lead identification or optimiza-
tion phase that represents ∼60% of failure rate (2). Conse-
quently, the computational evaluation of target druggabil-
ity, prior to the investment of resources, has become cru-
cial for the clinical progression of compounds. Many com-
putational approaches have been developed to predict tar-
get druggability before extensive time and money are in-
vestigated and to reduce the high failure rate. These com-
putational prediction methods involve pocket estimation,
i.e. identifying the atoms that form the binding pocket (see
Pe´rot et al. (3) for a review of pocket estimation methods),
which is a key issue as there is no consensus pocket esti-
mation method. Estimation of the same binding site us-
ing various estimation methods may result in different es-
timated pockets (4). Presently, each of the existing drugga-
bility models (DrugPred (5), Desaphy’s model (6), fpocket
score (7), SiteMap (8), DoGSiteScorer (9)) and existing
web servers (fpocket website (10), DoGSiteScorer website
(11), DrugEBIlity web service (available on the url: https:
//www.ebi.ac.uk/chembl/drugebility), iDrug website (12) or
PLIC website (13)) can compute pocket druggability. How-
ever these models and websites are attached to one particu-
lar pocket estimation method despite pocket estimation un-
certainties and are not optimized to be efficient using vari-
ous estimation methods. Current computational druggabil-
ity models based on pocket estimation methods guided by
the ligand position (extracted by proximity to a ligand) give
good results such as DrugPred (5) or Desaphy’s model (6).
In contrast, druggability models based on pocket estima-
tion methods fully independent of the ligand position (au-
tomatically predicted as the atoms that form the surface of
potential binding cavities) perform less well but are extend-
able to crucial druggability prediction of apo pockets (i.e.
fpocket score (7) and DoGSiteScorer (9)).
In this context, proposing drugabbility web server able to
accurately predict holo but also apo pocket druggability re-
gardless the pocket estimation method used is required for
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drug discovery. In this paper, we present PockDrug-Server
based on druggability prediction model constructed to be
efficient for different pocket estimations methods (4). Com-
pared to the existing druggability models, accuracies are
∼5–10% point higher than the results obtained in previ-
ous studies (6,8) on the same apo set. PockDrug-Server is a
pocket druggability prediction server robust with respect to
pocket boundaries uncertainties. Indeed, druggability pre-
diction can be carried out from a protein or a set of pro-
teins, using default pocket estimation methods, (guided or
not by the ligand position) or from any pocket previously
estimated by the user.
PockDrug druggability model
Protein datasets and pocket estimation methods. The first
set used to construct PockDrug druggability model was the
largest currently freely available dataset, i.e. the ‘NonRe-
dundant dataset of Druggable and Less Druggable bind-
ing sites’ (NRDLD), proposed by Krasowski et al. (5). The
NRDLD set contains 113 non-redundant complex proteins
sharing a pairwise sequence identity of less than 60% and
includes a large diversity of enzymes, such as oxidoreduc-
tases, ligases and hydrolases. It corresponds to 71 pockets
classified as druggable (i.e. binding site that non-covalently
binds small drug-like molecules, which are orally available
and do not require administration as prodrugs) and 42 as
less druggable, as defined by Krasowski et al. (5). Later, this
NRDLD set was split into one training set and one indepen-
dent test set, based on the identical division used by Kra-
sowski et al. (5) and Desaphy et al. (6).
The second pocket set used to validate PockDrug model
when extrapoling to apo pockets, was collected from
the ‘Druggable Cavity Directory’ (DCD) database (http:
//fpocket.sourceforge.net/dcd), proposed by Schmidtke et
al. (7). It includes 139 proteins in the apo form (later re-
ferred to as Apo139), all of which have an equivalent holo
form; 132 were classified as druggable.
During PockDrug model construction, different pocket
estimation methods were considered: (i) estimation method
guided by the ligand position information corresponds to
the extraction of protein atoms localized within two fixed
distance thresholds of 4 and 5.5 A˚ from a binding ligand,
respectively known as prox4 and prox5.5; (ii) the two con-
sidered pocket estimationmethods, not guided by the ligand
position, are fpocket (14) and DoGSite (15), recently used
(16–19) and proposing their own druggability prediction
methods: pocket druggability score (7) and DoGSiteScorer
(9). NRDLD pocket set was estimated using these four dif-
ferent pocket estimation methods. Apo139 pocket set was
estimated using two different pocket estimation methods
not guided by the ligand position.
PockDrug model construction. PockDrug model is an op-
timized druggability model develop by Borrel et al. (4)
obtained from three statistical steps: (i) optimization of
linear discriminant analysis models combining a selection
of pocket descriptors from a pool of 52 geometrical and
physicochemical descriptors by cross-validation using train-
ing part of NRDLD set estimated by fpocket, (ii) the se-
lection of seven most stable and efficient models using
NRDLD independent test set estimated using four differ-
ent pocket estimation methods, (iii) the construction of
one unique consensus druggability model: PockDrug from
the best models. PockDrug model provides, as output, one
druggability probability corresponding to the average of the
probabilities of the seven best models and its associated
standard deviation. PockDrug model is able to clearly dis-
tinguish a druggable pocket with an average druggability
probability of 0.87± 0.15 from a less druggable pocket, with
an average of 0.18 ± 0.15 using NRDLD set estimated by
four estimation methods. PockDrug model selects descrip-
tors that exhibit both the properties of being connected to
druggability and robustness with respect to the pocket esti-
mation uncertainties in order to efficiently predict the drug-
gability of different estimated pockets. The seven best mod-
els included in PockDrug model are based on hydrophobic
information combined with volume information, comple-
mented by aromatic information or the pocket composition
of hydroxyl group (see PockDrug part of Figure 1). For de-
scriptors definition, see Supplementary Tables S3 and S4 of
the Supplementary Data.
PockDrug model validation. The PockDrug model per-
formances in terms of accuracy, sensitivity, specificity and
Matthew’s correlation coefficient (MCC) using NRDLD
test set estimated by four different estimation methods
(prox4, prox5.5, fpocket and DoGSite) have been evalu-
ated in Borrel et al. study (4). Performance variability ac-
cording to different pocket estimation methods illustrates
the influence of the pocket estimations on the druggabil-
ity performance. But interestingly, PockDrug model ex-
hibits good performances with accuracies >83% (up to
94.6%) andMCC>0.650 (up to 0.885) whatever the pocket
estimation methods are. This confirms PockDrug model
ability to overcome the pocket estimation uncertainties to
predict pocket druggability. Among druggability models
based on pocket estimations not guided by the ligand posi-
tion (fpocket score (7) and DoGSiteScorer (9)), PockDrug
model outperformed by at least 10% points in terms of ac-
curacy and 0.2 in terms ofMCC using identically estimated
test set.
Table 1 shows that PockDrug model applied to apo
pocket set exhibited high performance with an average ac-
curacy of 92.5% and a MCC of 0.48. PockDrug model in-
creased MCC to more than 0.20 and the accuracy to more
than 20% points compared to the two recent druggability
prediction models, DoGSiteScorer and fpocket score ap-
plied to identically estimated apo pocket set. Taking into
account pocket size for the pocket druggability prediction
is crucial as pointed out by Gao and Skolnick (20). These
authors excluded cavities having <10 residues from their
pockets analysis. Hence, PockDrug-Server recommends a
careful examination of pockets predicted as druggable and
having <14 residues as these types of pockets correspond
only to 10% of NRDLD and Perola druggable pockets (21)
sets. For instance, pockets exhibiting >10 residues but <14
can correspond either to smallest druggable pockets or to
decoy pockets (as defined by Hajduk et al. (22)).
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Figure 1. Workflow presenting the different steps of PockDrug-Server protocol. It is divided into four main parts, from top to bottom: input information
(in clear blue), pocket estimation methods (in pink), PockDrug druggability prediction (in green) and the output display (in blue).
Table 1. PockDrug, fpocket score and DoGSiteScorer druggability models performances in terms of accuracy, sensitivity, specificity and Matthew’s cor-
relation coefficient (MCC) using Apo139 pocket sets estimated using fpocket and DoGSite
Druggability models PockDrug model fpocket score DoGSiteScorer
Pocket estimation methods fpocket DoGSite fpocket DoGSite
Accuracy 91.4 93.5 47.5 79.1
Sensitivity 92.4 94.7 44.7 78.8
Specificity 71.4 71.4 100 85.7
MCC 0.45 0.515 0.198 0.328
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The PockDrug-Server interface
Workflow.
Input. Themain function of PockDrug-Server is to predict
pocket druggability. To do so, two types of query can be
submitted:
(i) Pocket structure, which corresponds to a PDB format
file listing the atom pocket coordinates. The correspond-
ing protein PDB file is also required to compute pocket
descriptors and their predicted druggability probability.
(ii) Protein structure, which corresponds to a PDB code, a
PDB protein file or a file of PDB code list. For this type of
query PockDrug-Server protocol is divided into two main
steps:
- Step 1: pocket(s) estimation using one or both different
pocket estimation methods proposed by our web server;
- Step 2: pocket druggability probability prediction. For
each pocket, previously estimated in step 1, pocket drug-
gability probability and standard deviation are provided
by PockDrug model.
Protein query can be an apo or a holo protein. In the case
of a holo-protein the ligand can be included in the protein
file or uploaded apart so an optional field for ligand infor-
mation is additionally proposed.
The user can also submit a single job for a set of apo or
holo proteins in the form of a list of PDB codes. In this case
the same previous protocol is applied so for each PDB code
included in the list, pocket(s) is (are) estimated and its cor-
responding druggability probability is then predicted.
PockDrug-Server pocket estimation methods. When the
submitted input corresponds to protein structure (Input
case i) one or two proposed pocket estimation methods
could be selected: prox or/and fpocket.
- Prox method, is based on ligand proximity information
giving the user the possibility of choosing a threshold go-
ing from 4 to 12 A˚ (by step of 0.5 A˚) in order to extract the
protein atoms localized within the chosen distance of the
ligand. Indeed, this threshold choice was recently shown
to have a strong influence on the pocket descriptors (23)
and it seems pertinent to give the user the opportunity to
choose it. Two commonly used distance thresholds are rec-
ommended: 4 A˚ as used by Krasowski et al. (5), to enable
the extraction of a well-defined pocket limited to short lig-
and interactions (as hydrogen bonds or ionic interactions)
and 5.5 A˚, to enable the identification of all significant
contact points and a more complete environment of the
binding site. This method is suitable for holo-proteins and
threshold of 4 A˚ is chosen by default.
- Fpocket estimation method, not guided by the ligand in-
formation, is an automated geometry-basedmethod based
on the decomposition of a 3D protein into Voronoi poly-
hedrals. It extracts all the pockets from the apo- or holo-
protein surface using spheres of varying diameters. Its ad-
vantages include calculation speed and satisfactory perfor-
mance in terms of overlaying known binding sites with the
predicted sites (7). This method is used by default since it
is suitable for both apo- and holo- proteins.
Output: Pocket descriptors and druggability prediction.
The output page may consist of one or two tab(s), vary-
ing accordingly to the choice of one or two estimation
method(s): one result tab per selected estimation method.
Relative to the input type, two result displays are possible:
(i) If the submitted query corresponds to a single pocket
structure or a single protein entry (PDB code or PDB file)
each tab is structured as following:
(a) Sortable table(s): 1 or 2 tables can be provided for each
query; one table corresponding to pockets having at least
14 residues, and if necessary, a second table displaying
smaller pockets (<14 residues), in order to help the user
to distinguish the decoys from pockets:
(1) In table 1, corresponding pockets with more than 14
residues are large enough to bind a ligand and the drug-
gability probability can be directly interpreted.
(2) In table 2, pockets with a number of residues ranged
between 10 and 13, displayed in grey, have to be exam-
ined carefully. Cavities with <10 residues, too small to
be considered as pockets, are indicated in grey, italic
and highlighted using ‘◦’ sign.
These tables provide for each pocket:
- 6 out of the 17 pocket descriptors available in
PockDrug-Server (see PockDrug Model construction
section and Supplementary Table S3). As pocket es-
timation method affects directly the descriptors val-
ues, the descriptor averages with associated standard
deviations computed on NRDLD set estimated us-
ing three different estimations (prox4, prox5.5 and
fpocket) are given as reference (Supplementary Table
S4) to facilitate the user analysis of the pocket descrip-
tor values.
- The average druggability probability and its associ-
ated standard deviation that indicates the druggabil-
ity probability confidence on the seven best models in-
cluded in PockDrug. For a probability greater than
0.5, pockets are considered as druggable. In the case
where several pockets are considered, the table can
be ordered in ascending or descending order of drug-
gability probability to facilitate the identification of
druggable pockets.
(b) Pocket visualization using the Jmol web browser applet
(24) pocket(s) and protein structures can be visualized
and manipulated on the server through jmol applet. All
computed results: pockets structures, eleven descriptors
and druggability scores can be downloaded.
(c) Compressed file containing all the results can be down-
loaded using the download button. Only when the pock-
ets are estimated using both fpocket and prox (for all dis-
tance threshold), overlapping scores between two pocket
estimations are also computed and provided to the user
through the compressed result file in order to allow
pocket estimation comparisons and correspondence be-
tween two estimation methods. See section of pocket
comparison in the supplementary data for the definition
of overlapping scores. A bookmark button saving the
link on which the user can follow the evolution of his
job, access and download it within 7 days.
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(ii) If the submitted query corresponds to a list of PDB
codes, each tab corresponds to a sortable table showing:
- Protein PDB code: giving access to the detailed result
page as it is described previously in this paragraph (case
i)
- Number of estimated pockets (for each method)
- Number of druggable pockets (druggability probability
greater than 0.5)
- The highest druggability probability and its standard de-
viation
Computation time. Once the job is submitted, all the in-
put data is checked and the computation begins on our
server. A holding page, giving the link on which the user can
check the progress of his job is displayed while awaiting the
end of calculations. Computation time is relatively short;
it mainly depends on the protein and pocket size and the
choice of estimation methods as well. Generally, the com-
putation takes approximately a minute to a medium-sized
protein or a pocket entry. Calculation time can be longer
for a dataset (file of PDB code list). During the submission,
the user can optionally provide his email address to be no-
tified once the job is done and receive results. This option is
recommended in the case of a PDB list.
In order to test the server and to reduce computational
time delays, the whole RCSB Protein Data Bank (25) was
downloaded, all pocket estimations using two proposed
estimation methods (prox4 and fpocket) and pocket de-
scriptor computations were performed. Resulting associ-
ated druggability probabilities of pockets estimated were
pre-computed and stored on our servers. Therefore, dis-
playing results tends to be relatively fast. Calculations for
the other prox method thresholds are being generated. A
monthly automatic update of our database is implemented
by adding new PDB entries that are recently included in the
PDB. If one user query is a PDB code not pre-included in
our database, the results will be added to our pool.
Web server implementation. The entire web server has
been implemented using Python, HTML, CSS and
Javascript. Jmol Applet has been used for the protein
3D structure visualization. The descriptor computation
scripts have been written in python and bash while the
PockDrug LDA model has been developed using R. Ex-
ternal softwares have been also used: fpocket (14), RADI,
available in website http://petitjeanmichel.free.fr/itoweb.
petitjean.freeware.html, NACCESS V2.1.1, available in the
website http://www.bioinf.manchester.ac.uk/naccess/ and
Open Babel (26).
A comprehensive help section is available on the website
to help the user understand each of the steps involved and
infer the output of the results produced in the workflow.
Acetylcholinesterase, an example of target with several pock-
ets predicted as druggable. Here, we present an example of
the acetylcholinesterase (AChE) protein. AChE Irreversible
inhibitors may have various serious effects some of which
can be fatal. In contrast reversible inhibitors, occupying
also the esteratic site, are used to treat a range of central
nervous system diseases. Several cholinesterase inhibitors
are currently either being used for symptomatic treatment
of Alzheimer’s disease or are in advanced clinical trials. We
choose the AChE holo-protein complexed with the anti-
alzheimer drug E20 marketed as Ariceptand (PDB code
1EVE) (27). This protein consisting of 534 residues, was
used for recent computational investigations (28,29). AChe,
denoted as 1eve for the rest of this study, was not included
in the training set used to build PockDrug model. The
E20 binding pocket is tested by PockDrug-Server. A first
query consists on the using of an external pocket estimation
method (DoGSite, input case i), (see results in output part
of the Figure 1). PockDrug-Server returns an average drug-
gability probability of 0.98 (±0.01). When the same pocket
is estimated and directly predicted by DoGSiteScorer (9),
an ambiguous druggability score of 0.56 is assigned for
this pocket, ranking it as a ‘potentially/difficult druggable
pocket’. PockDrug-Server result is in a good agreement
with the literature (30) and the annotation ofDCDdatabase
confirming that E20 binding site corresponds to a druggable
pocket. 1EVE pockets are also estimated using PockDrug-
Server default estimation methods (prox4 and fpocket) and
are displayed in Figure 2. Corresponding druggability pre-
diction was performed in ∼50 s. Overlapping scores (see
Supplementary Data, Supplementary Tables S1 and S2)
show that estimated pocket noted P0 by fpocket corre-
sponds to the pocket binding, noted E20 by prox4 (Fig-
ure 2A). PockDrug-Server results in consistent high average
druggability probabilities of 0.95 (±0.06) when estimated
by prox4 (Figure 2A), of 0.97(± 0.02) when estimated by
prox5.5 and of 0.86 (±0.04) when estimated by fpocket (Fig-
ure 2B). Whatever the pocket estimation method is, Pock-
Drug druggability predictions are relatively similar con-
firming that in this case PockDrug model is able to over-
come the pocket estimation uncertainties.
Interestingly, in addition to pocket binding E20, out
of 16 estimated pockets using fpocket estimation method
PockDrug-Server predicted five other pockets as druggable.
These five pockets correspond to high druggability proba-
bilities (more than 0.63) and could be of interest in the case
of AChE, which is an important target to treat alzheimer
disease and other central nervous system diseases. So com-
bining different pocket estimationmethods, especially those
that do not need any prior ligand position information, al-
lows the identification of new potential druggable pockets.
N-Acetyl-D-Glucosamine (NAG), a natural co-enzyme,
is also present in 1EVE PDB, as a ligand, binding four
different pockets on the surface of this protein. As shown
in Figure 2, the pocket binding the NAG2 analysed by
PockDrug-Server, using prox4 is predicted as ‘may be drug-
gable’ (0.64 ± 0.1) and confirmed as druggable pocket with
a mean druggability probability of 0.7 (±0.02) when esti-
mated by fpocket. This case of figure shows the importance
to have different pocket estimation methods and a robust
model to compare pockets. It proves also that identifying
new druggable pockets can be beneficial to propose other
drugs candidates.
DISCUSSION
PockDrug-Server proposes druggability prediction from
pocket estimated using different pocket estimation meth-
ods. Compared to the existing models, accuracies are ∼5–
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Figure 2. Example of PockDrug-Server output using acetylcholinesterase protein structure (1EVE). (A) The results display of pocket estimated using prox4
estimationmethod sorted by descending order of druggability probability; (B) the result display of pocket estimated using fpocket estimationmethod sorted
by descending order of druggability probability.
10% points higher than the results obtained in previous
studies on the same apo set.
On one hand, the originality of PockDrug-Server is that
it provides the average druggability probability with its cor-
responding standard deviation that gives an idea about the
predictions variation and thus we can be confident that the
result will occur.
On the other hand, different methods of pocket estima-
tion that have been used to construct PockDrug model en-
able us to provide, to our knowledge, the unique free web
server proposing a druggability prediction that overcomes
the limits and inaccuracies of pocket estimations and is ef-
ficient with different pocket estimation methods.
In addition, the opportunity given by our web server to
directly submit a pocket of interest, estimated based on the
user expertise in the domain is of major importance.
The fact that PockDrug-Server accepts as input any
structure in the PDB format, the user can estimate and
predict pockets druggability not only for X-Ray or nuclear
magnetic resonance structures but also for models obtained
by homology (apo form) or by docking (holo form).
Many services are combined and proposed by PockDrug-
Server: (i) predicting pocket druggability probability for
any estimated pocket regardless to what pocket estima-
tion method is used, (ii) proposing two pocket estimation
method(s) (iii) in the case where the pocket is estimated by
proximity to the ligand, a range of distance threshold can be
chosen by the user (default 4 or 5.5 A˚), (iv) proposing to the
user to use his own estimation method based on his knowl-
edge of the protein and pockets or in the case of pockets
difficult to estimate (v) submitting a protein set is also pos-
sible to facilitate the research––which is not the case with
other druggability web servers and (vi) finally all the results
can be visualized online and can be also downloaded with
some supplementary data (overlapping scores, descriptors
reference average) that help users understand and analyse
the results of their job.
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CONCLUSION
PockDrug-Server is part of an important initiative of our
team study to provide an online tool for computer-aided
drug discovery. PockDrug-Server could be, for instance,
useful for druggability assessment to evaluate whether a
compound development project is worth starting after
an X-ray structure is available. It is also beneficial for
ranking/prioritizing the pockets of an orphan protein to
choose one suitable pocket for compound development in
structure-based drug design or finding a druggable sec-
ondary pocket as well as for identifying a target in a disease-
modifying pathway to compare druggability predictions
and select which protein is most pertinent to study in a set
of proteins. The future aimwill be constructing a pipeline to
allow the user to predict pocket druggability probabilities,
to profile drug-like molecules for each druggable pocket or
to predict any interaction that it could have with targets dif-
ferent than its primary target in an attempt to predict any
side effects.
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